Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    11493438 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Rituximab;   Drug: Dexamethasone;   Drug: Mycophenolate mofetil;   Drug: Placebo
2 Completed
Has Results
Rituximab in the Treatment of Patients With Bullous Pemphigoid
Condition: Bullous Pemphigoid
Intervention: Drug: Rituximab
3 Completed Rituximab in Active Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Rituximab

Indicates status has not been verified in more than two years